Preventing and experiencing ischemic heart disease as a woman: State of the science: A scientific statement from the American Heart Association

Circulation

Volumn 133, Issue 13, 2016, Pages 1302-1331

  McSweeney, Jean C ^a   Rosenfeld, Anne G ^a   Abel, Willie M ^a   Braun, Lynne T ^a   Burke, Lora E ^a   Daugherty, Stacie L ^a   Fletcher, Gerald F ^a   Gulati, Martha ^a   Mehta, Laxmi S ^a   Pettey, Christina ^a   Reckelhoff, Jane F ^a  

^a NONE

Author keywords

AHA Scientific Statements; myocardial ischemia; prevention and control; women

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ACUTE HEART INFARCTION; AGE; AGING; AUTOIMMUNE DISEASE; AWARENESS; BEHAVIOR CHANGE; BREAST CANCER; CARDIAC IMAGING; CULTURAL ANTHROPOLOGY; DIABETES MELLITUS; DISABILITY; DYSLIPIDEMIA; ETHNICITY; GENOMICS; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEART MUSCLE ISCHEMIA; HOSPITAL READMISSION; HUMAN; HYPERTENSION; HYPOTHALAMIC AMENORRHEA; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; METABOLIC SYNDROME X; MORTALITY; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; POSTMENOPAUSE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PSYCHOSOCIAL CARE; PUBLIC HEALTH; RACE; RECOGNITION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; STEREOTYPY; TOBACCO USE; FEMALE; MYOCARDIAL ISCHEMIA; PRACTICE GUIDELINE; STANDARDS; TRENDS; UNITED STATES; WOMEN'S HEALTH;

AMERICAN HEART ASSOCIATION; FEMALE; HUMANS; MYOCARDIAL ISCHEMIA; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; WOMEN'S HEALTH;

EID: 84959258350     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000381     Document Type: Review

References (345)

1. Wizemann TM, Pardur ML, Exploring the Biological Contributions to Human Health: Does Sex Matter? 2001 Washington, DC National Academies Press
2. McGregor AJ, Templeton K, Kleinman MR, Jenkins MR, Advancing sex and gender competency in medicine: Sex & Gender Women's Health Collaborative. Biol Sex Differ 2013 4 11. doi: 10.1186/2042-6410-4-11.
3. Allen J, Szanton S, Gender, ethnicity, and cardiovascular disease. J Cardiovasc Nurs 2005 20 1 6; quiz 7-8
4. Deleted in proof.
5. Sharaf B, Wood T, Shaw L, Johnson BD, Kelsey S, Anderson RD, Pepine CJ, Bairey Merz CN, Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. Am Heart J 2013 166 134 141. doi: 10.1016/j.ahj.2013.04.002.
6. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, Jørgensen E, Kelbæk H, Prescott E, Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012 33 734 744. doi: 10.1093/eurheartj/ehr331.
7. Dickerson JA, Nagaraja HN, Raman SV, Gender-related differences in coronary artery dimensions: a volumetric analysis. Clin Cardiol 2010 33 E44 E49. doi: 10.1002/clc.20509.
8. Finks S, Cardiovascular disease in women. In: Pharmacotherapy Self-Assessment Program, Seventh Edition (PSAP-VII), Book 1 (Cardiology) 2010 Lenexa, KS American College of Clinical Pharmacy 182
9. Shehab A, Al-Dabbagh B, AlHabib KF, Alsheikh-Ali AA, Almahmeed W, Sulaiman K, Al-Motarreb A, Nagelkerke N, Al Suwaidi J, Hersi A, Al Faleh H, Asaad N, Al Saif S, Amin H, Gender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). PLoS One 2013 8 e55508. doi: 10.1371/journal.pone.0055508.
10. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED, American College of Cardiology-National Cardiovascular Data Registry Investigators Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2008 117 1787 1801. doi: 10.1161/CIRCULATIONAHA.107.726562.
11. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association [published correction appears in Circulation. 2015;131:e535]. Circulation 2015 131 e29 e322. doi: 10.1161/CIR.0000000000000152.
12. Yang XP, Reckelhoff JF, Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 2011 20 133 138. doi: 10.1097/MNH.0b013e3283431921.
13. Mosca L, Barrett-Connor E, Wenger NK, Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011 124 2145 2154. doi: 10.1161/CIRCULATIONAHA.110.968792.
14. Ford ES, Capewell S, Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007 50 2128 2132. doi: 10.1016/j.jacc.2007.05.056.
15. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292. doi: 10.1161/01.cir.0000441139.02102.80.
16. Egede LE, Race, ethnicity, culture, and disparities in health care. J Gen Intern Med 2006 21 667 669. doi: 10.1111/j.1525-1497.2006.0512.x.
17. Human Genome Program of the US Department of Energy Office of Science's Office of Biological and Environmental Research Exploring genetics issues relevant to minority communities 2003. http://web.ornl.gov/sci/techresources/Human-Genome/publicat/MinorityConcerns-82.pdf. Accessed December 15, 2015
18. Smedley A, Origin of the idea of race: anthropology newsletter. 1997 Public Broadcasting Service. http://www.pbs.org/race/000-About/002-04-background-02-09.htm. Accessed December 15, 2015.
19. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention: leading causes of death in females 2015. http://www.cdc.gov/women/lcod/. Accessed December 15, 2015.
20. Hastings KG, Jose PO, Kapphahn KI, Frank AT, Goldstein BA, Thompson CA, Eggleston K, Cullen MR, Palaniappan LP, Leading causes of death among Asian American subgroups (2003-2011). PLoS One 2015 10 e0124341. doi: 10.1371/journal.pone.0124341.
21. Sayols-Baixeras S, Lluís-Ganella C, Lucas G, Elosua R, Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet 2014 7 15 32. doi: 10.2147/TACG.S35301.
22. Fox CS, Hall JL, Arnett DK, Ashley EA, Delles C, Engler MB, Freeman MW, Johnson JA, Lanfear DE, Liggett SB, Lusis AJ, Loscalzo J, MacRae CA, Musunuru K, Newby LK, O'Donnell CJ, Rich SS, Terzic A, on behalf of the American Heart Association Council on Functional Genomics and Translational Biology, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Quality of Care and Outcomes Research, and Council on Epidemiology and Prevention Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. Circulation 2015 131 1715 1736. doi: 10.1161/CIR.0000000000000211.
23. Musunuru K, Hickey KT, Al-Khatib SM, Delles C, Fornage M, Fox CS, Frazier L, Gelb BD, Herrington DM, Lanfear DE, Rosand J, on behalf of the American Heart Association Council on Functional Genomics and Translational Biology, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Hypertension, Council on Lifestyle and Cardiometabolic Health, Council on Quality of Care and Outcomes Research, and Stroke Council Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association [published correction appears in Circ Cardiovasc Genet. 2015;8:243]. Circ Cardiovasc Genet 2015 8 216 242. doi: 10.1161/HCG.0000000000000020.
24. Brittingham A, de la Cruz P, Ancestry: 2000 Census 2000 brief. 2004 US Census Bureau. http://www.census.gov/prod/2004pubs/c2kbr-35.pdf. Accessed December 15, 2015
25. Benson J, Maldari T, Williams J, Hanifi H, The impact of culture and ethnicity on women's perceived role in society and their attendant health beliefs. InnovAiT: Education and Inspiration for General Practice 2010 3 358 365
26. Lang T, Lepage B, Schieber AC, Lamy S, Kelly-Irving M, Social determinants of cardiovascular diseases. Public Health Rev 2012 33 601 622
27. Newby DE, Mannucci PM, Tell GS, Baccarelli AA, Brook RD, Donaldson K, Forastiere F, Franchini M, Franco OH, Graham I, Hoek G, Hoffmann B, Hoylaerts MF, Künzli N, Mills N, Pekkanen J, Peters A, Piepoli MF, Rajagopalan S, Storey RF, ESC Working Group on Thrombosis, European Association for Cardiovascular Prevention and Rehabilitation; ESC Heart Failure Association Expert position paper on air pollution and cardiovascular disease. Eur Heart J 2015 36 83 93b. doi: 10.1093/eurheartj/ehu458.
28. Finkelstein EA, Khavjou OA, Mobley LR, Haney DM, Will JC, Racial/ethnic disparities in coronary heart disease risk factors among WISEWOMAN enrollees. J Womens Health (Larchmt) 2004 13 503 518. doi: 10.1089/1540999041280963.
29. Lichtman JH, Wang Y, Jones SB, Leifheit-Limson EC, Shaw LJ, Vaccarino V, Rumsfeld JS, Krumholz HM, Curtis JP, Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR(®). Am Heart J 2014 167 376 383. doi: 10.1016/j.ahj.2013.11.001.
30. Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, Ohman EM, Newby LK, Peterson ED, Hochman JS, Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009 158 688 694. doi: 10.1016/j.ahj.2009.08.004.
31. Sedlak TL, Lee M, Izadnegahdar M, Merz CN, Gao M, Humphries KH, Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J 2013 166 38 44. doi: 10.1016/j.ahj.2013.03.015.
32. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN, Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009 169 843 850. doi: 10.1001/archinternmed.2009.50.
33. Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KA, Newby DE, Mills NL, High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study [published correction appears in BMJ. 2015;350:h626]. BMJ 2015 350 g7873
34. Shah AS, Newby DE, Mills NL, High sensitivity cardiac troponin in patients with chest pain. BMJ 2013 347 f4222
35. Norris CM, Ghali WA, Galbraith PD, Graham MM, Jensen LA, Knudtson ML, APPROACH Investigators Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual Life Outcomes 2004 2 21 31. doi: 10.1186/1477-7525-2-21.
36. Norris CM, Hegadoren K, Pilote L, Depression symptoms have a greater impact on the 1-year health-related quality of life outcomes of women post-myocardial infarction compared to men. Eur J Cardiovasc Nurs 2007 6 92 98. doi: 10.1016/j.ejcnurse.2006.05.003.
37. Norris CM, Spertus JA, Jensen L, Johnson J, Hegadoren KM, Ghali WA, APPROACH Investigators Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circ Cardiovasc Qual Outcomes 2008 1 123 130. doi: 10.1161/CIRCOUTCOMES.108.793448.
38. Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Mankad S, Rogers WJ, Sopko G, Cornell CE, Sharaf B, Merz CN, Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study. Psychosom Med 2006 68 217 223. doi: 10.1097/01.psy.0000195751.94998.e3.
39. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, on behalf of the American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia; Interdisciplinary Council on Quality of Care and Outcomes Research Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011 123 933 944. doi: 10.1161/CIR.0b013e31820a55f5.
40. Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G, on behalf of the Women's Ischemia Syndrome Evaluation (WISE) Investigators The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation 2006 114 894 904. doi: 10.1161/CIRCULATIONAHA.105.609990.
41. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA, on behalf of the American Heart Association Cardiovascular Disease and Stroke in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on High Blood Pressure Research, Council on Nutrition, Physical Activity and Metabolism Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation 2013 127 1254 1263, e1 e29. doi: 10.1161/CIR.0b013e318287cf2f.
42. Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN, Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med 2000 9 506 515
43. Asia Pacific Cohort Studies Collaboration The impact of cardiovascular risk factors on the age-related excess risk of coronary heart disease. Int J Epidemiol 2006 35 1025 1033
44. Shaw LJ, Bugiardini R, Merz CN, Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 2009 54 1561 1575. doi: 10.1016/j.jacc.2009.04.098.
45. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 937 952. doi: 10.1016/S0140-6736(04)17018-9.
46. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006 47 suppl S4 S20. doi: 10.1016/j.jacc.2005.01.072.
47. Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, Liu K, Wang R, Dyer AR, Lloyd-Jones DM, Greenland P, Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 2004 292 1588 1592. doi: 10.1001/jama.292.13.1588.
48. Spencer EA, Pirie KL, Stevens RJ, Beral V, Brown A, Liu B, Green J, Reeves GK, Million Women Study Collaborators Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study. Eur J Epidemiol 2008 23 793 799. doi: 10.1007/s10654-008-9298-3.
49. Jónsdóttir LS, Sigfússon N, Gudnason V, Sigvaldason H, Thorgeirsson G, Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 2002 9 67 76
50. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG, Coronary heart disease risk factors ranked by importance for the individual and community: a 21 year follow-up of 12 000 men and women from the Copenhagen City Heart Study. Eur Heart J 2002 23 620 626. doi: 10.1053/euhj.2001.2842.
51. Ko DT, Wijeysundera HC, Udell JA, Vaccarino V, Austin PC, Guo H, Velianou JL, Lau K, Tu JV, Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and women. Can J Cardiol 2014 30 820 826. doi: 10.1016/j.cjca.2014.04.032.
52. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(suppl 2):S74-S75]. Circulation 2014 129 suppl 2 S49 S73. doi: 10.1161/01.cir.0000437741.48606.98.
53. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS, Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006 184 201 206. doi: 10.1016/j.atherosclerosis.2005.04.004.
54. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS, Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2007 167 2437 2442. doi: 10.1001/archinte.167.22.2437.
55. Haukkala A, Konttinen H, Uutela A, Kawachi I, Laatikainen T, Gender differences in the associations between depressive symptoms, cardiovascular diseases, and all-cause mortality. Ann Epidemiol 2009 19 623 629. doi: 10.1016/j.annepidem.2009.01.010.
56. Low CA, Thurston RC, Matthews KA, Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom Med 2010 72 842 854. doi: 10.1097/PSY.0b013e3181f6934f.
57. Stewart JC, Janicki DL, Muldoon MF, Sutton-Tyrrell K, Kamarck TW, Negative emotions and 3-year progression of subclinical atherosclerosis. Arch Gen Psychiatry 2007 64 225 233. doi: 10.1001/archpsyc.64.2.225.
58. Chaput LA, Adams SH, Simon JA, Blumenthal RS, Vittinghoff E, Lin F, Loh E, Matthews KA, Hostility predicts recurrent events among postmenopausal women with coronary heart disease. Am J Epidemiol 2002 156 1092 1099
59. Olson MB, Krantz DS, Kelsey SF, Pepine CJ, Sopko G, Handberg E, Rogers WJ, Gierach GL, McClure CK, Merz CN, WISE Study Group Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study. Psychosom Med 2005 67 546 552. doi: 10.1097/01.psy.0000170830.99263.4e.
60. Horsten M, Mittleman MA, Wamala SP, Schenck-Gustafsson K, Orth-Gomér K, Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women: the Stockholm Female Coronary Risk Study. Eur Heart J 2000 21 1072 1080. doi: 10.1053/euhj.1999.2012.
61. Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Mankad S, Rogers WJ, Bairey Merz CN, Sopko G, Cornell CE, Sharaf B, Matthews KA, National Heart, Lung, and Blood Institute Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study. Psychosom Med 2004 66 882 888. doi: 10.1097/01.psy.0000145819.94041.52.
62. Thurston RC, Kubzansky LD, Women, loneliness, and incident coronary heart disease. Psychosom Med 2009 71 836 842. doi: 10.1097/PSY.0b013e3181b40efc.
63. Tindle HA, Chang YF, Kuller LH, Manson JE, Robinson JG, Rosal MC, Siegle GJ, Matthews KA, Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women's Health Initiative. Circulation 2009 120 656 662. doi: 10.1161/CIRCULATIONAHA.108.827642.
64. Kubzansky LD, Thurston RC, Emotional vitality and incident coronary heart disease: benefits of healthy psychological functioning. Arch Gen Psychiatry 2007 64 1393 1401. doi: 10.1001/archpsyc.64.12.1393.
65. Imes CC, Burke LE, The obesity epidemic: the United States as a cautionary tale for the rest of the world. Curr Epidemiol Rep 2014 1 82 88. doi: 10.1007/s40471-014-0012-6.
66. Centers for Disease Control and Prevention, Division of Nutrition, Physical Activity, and Obesity. Overweight and obesity: obesity prevalence maps 2013 2014. http://www.cdc.gov/obesity/data/prevalence-maps.html. Accessed December 15, 2015.
67. Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention 2014. Heart disease death rates, total population ages 35+. http://www.cdc.gov/dhdsp/maps/national-maps/hd-all.htm. Accessed December 15, 2015.
68. Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami HO, Ebbert JO, English DR, Gapstur SM, Giles GG, Horn-Ross PL, Park Y, Patel AV, Robien K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Hartge P, Bernstein L, Berrington de Gonzalez A, A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc 2014 89 335 345. doi: 10.1016/j.mayocp.2013.11.011.
69. Ford ES, Li C, Zhao G, Tsai J, Trends in obesity and abdominal obesity among adults in the United States from 1999-2008. Int J Obes (Lond) 2011 35 736 743. doi: 10.1038/ijo.2010.186.
70. Flegal KM, Carroll MD, Ogden CL, Curtin LR, Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010 303 235 241. doi: 10.1001/jama.2009.2014.
71. Lobo RA, Metabolic syndrome after menopause and the role of hormones. Maturitas 2008 60 10 18. doi: 10.1016/j.maturitas.2008.02.008.
72. Ozbey N, Sencer E, Molvalilar S, Orhan Y, Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J 2002 49 503 509
73. Wildman RP, McGinn AP, Lin J, Wang D, Muntner P, Cohen HW, Reynolds K, Fonseca V, Sowers MR, Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity (Silver Spring) 2011 19 853 860. doi: 10.1038/oby.2010.168.
74. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, Hachamovitch R, Friedman JD, Hayes S, Berman DS, The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003 41 1547 1553
75. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 683 689
76. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE, Women's Ischemia Syndrome Evaluation Investigators Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004 109 714 721. doi: 10.1161/01.CIR.0000115517.26897.A7.
77. Horvei LD, Brækkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Hansen JB, Obesity measures and risk of venous thromboembolism and myocardial infarction. Eur J Epidemiol 2014 29 821 830. doi: 10.1007/s10654-014-9950-z.
78. Diaconu CC, Paraschiv B, Clinical characteristics of obese patients with hypertension and chronic ischemic heart disease. Rom J Intern Med 2014 52 251 255
79. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE, Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004 109 706 713. doi: 10.1161/01.CIR.0000115514.44135.A8.
80. Li N, Katzmarzyk PT, Horswell R, Zhang Y, Li W, Zhao W, Wang Y, Johnson J, Hu G, BMI and coronary heart disease risk among low-income and underinsured diabetic patients. Diabetes Care 2014 37 3204 3212. doi: 10.2337/dc14-1091.
81. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE, The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001 161 1717 1723
82. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL, Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 2003 163 1735 1740. doi: 10.1001/archinte.163.14.1735.
83. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M, Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004 27 2898 2904
84. Natarajan S, Liao Y, Sinha D, Cao G, McGee DL, Lipsitz SR, Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 2005 165 430 435. doi: 10.1001/archinte.165.4.430.
85. Huxley R, Barzi F, Woodward M, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006 332 73 78. doi: 10.1136/bmj.38678.389583.7C.
86. Barrett-Connor E, The Rancho Bernardo Study: 40 years studying why women have less heart disease than men and how diabetes modifies women's usual cardiac protection. Glob Heart 2013 8. doi: 10.1016/j.gheart.2012.12.002.
87. Roche MM, Wang PP, Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care 2013 36 2582 2590. doi: 10.2337/dc12-1272.
88. Arnetz L, Ekberg NR, Alvarsson M, Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes 2014 7 409 420. doi: 10.2147/DMSO.S51301.
89. Lee C, Joseph L, Colosimo A, Dasgupta K, Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. Diabetes Metab 2012 38 420 427. doi: 10.1016/j.diabet.2012.04.002.
90. Peters SA, Huxley RR, Woodward M, Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 2014 57 1542 1551. doi: 10.1007/s00125-014-3260-6.
91. Huxley RR, Peters SA, Mishra GD, Woodward M, Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015 3 198 206. doi: 10.1016/S2213-8587(14)70248-7.
92. Kanaya AM, Grady D, Barrett-Connor E, Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002 162 1737 1745
93. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L, Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012 35 1252 1257. doi: 10.2337/dc11-1162.
94. Phan BA, Toth PP, Dyslipidemia in women: etiology and management. Int J Womens Health 2014 6 185 194. doi: 10.2147/IJWH.S38133.
95. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011 32 1769 1818
96. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published corrections appear in Circulation. 2014;129(suppl 2):S46-S48 and Circulation. 2015;132:e396]. Circulation 2014 129 suppl 2 S1 S45. doi: 10.1161/01.cir.0000437738.63853.7a.
97. Reiner Z, De Bacquer D, Kotseva K, Prugger C, De Backer G, Wood D, EUROASPIRE III Study Group Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. Atherosclerosis 2013 231 300 307
98. Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham IM, SCORE Investigators HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009 206 611 616. doi: 10.1016/j.atherosclerosis.2009.02.041.
99. Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN, Sopko G, The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2009 157 548 555. doi: 10.1016/j.ahj.2008.11.014.
100. Hokanson JE, Austin MA, Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996 3 213 219
101. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC, Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997 337 1491 1499. doi: 10.1056/NEJM199711203372102.
102. Victor BM, Teal V, Ahedor L, Karalis DG, Gender differences in achieving optimal lipid goals in patients with coronary artery disease. Am J Cardiol 2014 113 1611 1615. doi: 10.1016/j.amjcard.2014.02.018.
103. Abuful A, Gidron Y, Henkin Y, Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol 2005 28 389 393
104. Chou AF, Scholle SH, Weisman CS, Bierman AS, Correa-de-Araujo R, Mosca L, Gender disparities in the quality of cardiovascular disease care in private managed care plans. Womens Health Issues 2007 17 120 130. doi: 10.1016/j.whi.2007.03.002.
105. Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS, Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med 2008 5 53 61
106. Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W, Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 2008 31 1389 1391. doi: 10.2337/dc08-0194.
107. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E, Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005 28 514 520
108. National Institutes of Health, National Institute on Aging Your Everyday Guide from the National Institute on Aging: Exercise and Physical Activity. Publication no. 15-4258. Published May 2015. https://www.nia.nih.gov/health/publication/exercise-physical-activity/introduction. Accessed February 16, 2016
109. Fletcher GF, Current status of cardiac rehabilitation. Curr Probl Cardiol 1992 17 143 203
110. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association [published corrections appear in Circulation. 2013;127:e841 and Circulation. 2016;133:e417.]. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad.
111. McSweeney JC, Crane PB, An act of courage: women's decision-making processes regarding outpatient cardiac rehabilitation attendance. Rehabil Nurs 2001 26 132 140
112. Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF, The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: a randomized clinical trial. Int J Nurs Stud 2011 48 3 12. doi: 10.1016/j.ijnurstu.2010.06.005.
113. Colbert JD, Martin BJ, Haykowsky MJ, Hauer TL, Austford LD, Arena RA, Knudtson ML, Meldrum DA, Aggarwal SG, Stone JA, Cardiac rehabilitation referral, attendance and mortality in women. Eur J Prev Cardiol 2015 22 979 986. doi: 10.1177/2047487314545279.
114. Menezes AR, Lavie CJ, DeSchutter A, Milani RV, Gender, race and cardiac rehabilitation in the United States: is there a difference in care? Am J Med Sci 2014 348 146 152. doi: 10.1097/MAJ.0000000000000306.
115. Johnson D, Sacrinty M, Mehta H, Douglas C, Paladenech C, Robinson K, Cardiac rehabilitation in African Americans: evidence for poorer outcomes compared with whites, especially in women and diabetic participants. Am Heart J 2015 169 102 107. doi: 10.1016/j.ahj.2014.09.009.
116. Beckie TM, Fletcher G, Groer MW, Kip KE, Ji M, Biopsychosocial health disparities among young women enrolled in cardiac rehabilitation. J Cardiopulm Rehabil Prev 2015 35 103 113. doi: 10.1097/HCR.0000000000000095.
117. Andraos C, Arthur HM, Oh P, Chessex C, Brister S, Grace SL, Women's preferences for cardiac rehabilitation program model: a randomized controlled trial. Eur J Prev Cardiol 2015 22 1513 1522. doi: 10.1177/2047487314559275.
118. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA, on behalf of the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013 128 873 934. doi: 10.1161/CIR.0b013e31829b5b44.
119. Centers for Disease Control and Prevention. Adult smoking in the US 2011. http://www.cdc.gov/vitalsigns/AdultSmoking/index.html. Accessed December 15, 2015.
120. Ezzati M, Henley SJ, Thun MJ, Lopez AD, Role of smoking in global and regional cardiovascular mortality. Circulation 2005 112 489 497. doi: 10.1161/CIRCULATIONAHA.104.521708.
121. Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA, Burden of smoking on cause-specific mortality: application to the Nurses' Health Study. Tob Control 2010 19 248 254. doi: 10.1136/tc.2009.032839.
122. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S, INTERHEART Study Investigators Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006 368 647 658. doi: 10.1016/S0140-6736(06)69249-0.
123. Huxley RR, Woodward M, Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011 378 1297 1305. doi: 10.1016/S0140-6736(11)60781-2.
124. Bähler C, Gutzwiller F, Erne P, Radovanovic D, Lower age at first myocardial infarction in female compared to male smokers. Eur J Prev Cardiol 2012 19 1184 1193. doi: 10.1177/1741826711422764.
125. Tolstrup JS, Hvidtfeldt UA, Flachs EM, Spiegelman D, Heitmann BL, Bälter K, Goldbourt U, Hallmans G, Knekt P, Liu S, Pereira M, Stevens J, Virtamo J, Feskanich D, Smoking and risk of coronary heart disease in younger, middle-aged, and older adults. Am J Public Health 2014 104 96 102. doi: 10.2105/AJPH.2012.301091.
126. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH, Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 1994 154 169 175
127. Bjartveit K, Tverdal A, Health consequences of sustained smoking cessation. Tob Control 2009 18 197 205. doi: 10.1136/tc.2008.026898.
128. Critchley J, Capewell S, Smoking cessation for the secondary prevention of coronary heart disease [withdrawn in Cochrane Database Syst Rev. 2012;2:CD003041]. Cochrane Database Syst Rev 2004 CD003041
129. Critchley JA, Capewell S, Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003 290 86 97. doi: 10.1001/jama.290.1.86.
130. Ong KL, Tso AW, Lam KS, Cheung BM, Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 2008 51 1142 1148. doi: 10.1161/HYPERTENSIONAHA.107.105205.
131. Taddei S, Blood pressure through aging and menopause. Climacteric 2009 12 suppl 1 36 40
132. Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G, Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertil Steril 2009 92 1171 1186. doi: 10.1016/j.fertnstert.2009.06.032.
133. Sjoberg L, Kaaja R, Tuomilehto J, Epidemiology of postmenopausal hypertension. Int J Clin Pract Suppl 2004 4 12
134. Health, United States, 2010: With Special Feature on Death and Dying 2011 Hyattsville, MD National Center for Health Statistics. http://www.cdc.gov/nchs/data/hus/hus10.pdf. Accessed December 15, 2015
135. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, Global burden of hypertension: analysis of worldwide data. Lancet 2005 365 217 223. doi: 10.1016/S0140-6736(05)17741-1.
136. Kim JK, Alley D, Seeman T, Karlamangla A, Crimmins E, Recent changes in cardiovascular risk factors among women and men. J Womens Health (Larchmt) 2006 15 734 746. doi: 10.1089/jwh.2006.15.734.
137. Stolarz K, Staessen JA, O'Brien ET, Night-time blood pressure: dipping into the future? J Hypertens 2002 20 2131 2133
138. Routledge FS, McFetridge-Durdle JA, Dean CR, Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women. Can J Cardiol 2009 25 e157 e163
139. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G, Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension [published correction appears in Hypertension. 1995;25:462]. Hypertension 1994 24 793 801
140. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E, 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [published correction appears in JAMA. 2014;311:1809]. JAMA 2014 311 507 520. doi: 10.1001/jama.2013.284427.
141. Pelzer T, de Jager T, Muck J, Stimpel M, Neyses L, Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. J Hypertens 2002 20 1001 1006
142. Masood DE, Roach EC, Beauregard KG, Khalil RA, Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab 2010 11 693 714
143. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial: the Writing Group for the PEPI Trial [published correction appears in JAMA. 1995;274:1676]. JAMA 1995 273 199 208
144. Affinito P, Palomba S, Bonifacio M, Fontana D, Izzo R, Trimarco B, Nappi C, Effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas 2001 40 75 83
145. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 321 333
146. Herrington DM, The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Intern Med 1999 131 463 466
147. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [published correction appears in JAMA. 2002;288:1064]. JAMA 2002 288 49 57
148. Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K, Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin-aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women. Geriatr Gerontol Int 2008 8 259 264. doi: 10.1111/j.1447-0594.2008.00474.x.
149. Prelevic GM, Kwong P, Byrne DJ, Jagroop IA, Ginsburg J, Mikhailidis DP, A cross-sectional study of the effects of hormone replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women. Fertil Steril 2002 77 945 951
150. Harman SM, Vittinghoff E, Brinton EA, Budoff MJ, Cedars MI, Lobo RA, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Taylor HS, Black DM, Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med 2011 124 199 205. doi: 10.1016/j.amjmed.2010.09.021.
151. Olszanecka A, Pośnik-Urbańska A, Kawecka-Jaszcz K, Czarnecka D, Fedak D, Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women. Kardiol Pol 2010 68 753 760
152. Routledge FS, Hinderliter AL, McFetridge-Durdle J, Blumenthal JA, Paine NJ, Sherwood A, Endothelial function in postmenopausal women with nighttime systolic hypertension. Menopause 2015 22 857 863. doi: 10.1097/GME.0000000000000405.
153. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A, Menopause is associated with endothelial dysfunction in women. Hypertension 1996 28 576 582
154. Rossi R, Nuzzo A, Origliani G, Modena MG, Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 2008 51 997 1002. doi: 10.1016/j.jacc.2007.11.044.
155. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, Paraskevaidis EA, Sideris DA, Tsatsoulis A, Chrousos GP, Michalis LK, Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004 89 3907 3913. doi: 10.1210/jc.2004-0015.
156. Kelemen M, Vaidya D, Waters DD, Howard BV, Cobb F, Younes N, Tripputti M, Ouyang P, Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis 2005 179 193 200. doi: 10.1016/j.atherosclerosis.2004.09.021.
157. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S, Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994 91 5212 5216
158. Wyatt AW, Steinert JR, Mann GE, Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells. Biochem Soc Symp 2004 71 143 156
159. Iñarrea P, Casanova A, Alava MA, Iturralde M, Cadenas E, Melatonin and steroid hormones activate intermembrane Cu,Zn-superoxide dismutase by means of mitochondrial cytochrome P450. Free Radic Biol Med 2011 50 1575 1581. doi: 10.1016/j.freeradbiomed.2011.03.003.
160. Romero JC, Reckelhoff JF, State-of-the-art lecture: role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999 34 pt 2 943 949
161. Nickenig G, Bäumer AT, Grohè C, Kahlert S, Strehlow K, Rosenkranz S, Stäblein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Böhm M, Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 1998 97 2197 2201
162. Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ, Critchley HO, Newby DE, Wallace WH, Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 2009 53 805 811. doi: 10.1161/HYPERTENSIONAHA.108.126516.
163. Wassmann K, Ghiassi A, Wassmann S, Böhm M, Nickenig G, AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women. Maturitas 2006 53 176 183. doi: 10.1016/j.maturitas.2005.04.002.
164. Ridker PM, Hennekens CH, Buring JE, Rifai N, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000 342 836 843. doi: 10.1056/NEJM200003233421202.
165. Emerging Risk Factors Collaboration Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R., Davey-Smith G, Deeg D, Dekker JM, Engstrom G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J, Emerging Risk Factors Collaboration C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012 367 1310 1320
166. Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, Di Angelantonio E, Gudnason V, Rumley A, Lowe GD, Jørgensen T, Danesh J, Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J 2014 35 578 589. doi: 10.1093/eurheartj/eht367.
167. La Franca E, Caruso M, Sansone A, Iacona R, Ajello L, Mancuso D, Castellano F, Novo S, Assennato P, Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty. Glob J Health Sci 2013 5 48 54. doi: 10.5539/gjhs.v5n4p48.
168. Arant CB, Wessel TR, Ridker PM, Olson MB, Reis SE, Delia Johnson B, Sharaf BL, Pauly DF, Handberg E, Zineh I, Sopko G, Kelsey SF, Noel Bairey Merz C, Pepine CJ, Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Clin Cardiol 2009 32 244 250. doi: 10.1002/clc.20454.
169. Willeit P, Kiechl S, Kronenberg F, Witztum JL, Santer P, Mayr M, Xu Q, Mayr A, Willeit J, Tsimikas S, Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol 2014 64 851 860. doi: 10.1016/j.jacc.2014.03.061.
170. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, European Atherosclerosis Society Consensus Panel Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010 31 2844 2853. doi: 10.1093/eurheartj/ehq386.
171. Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR, Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol 2011 5 338 367. doi: 10.1016/j.jacl.2011.07.005.
172. Cook NR, Buring JE, Ridker PM, The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006 145 21 29
173. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 1557 1565. doi: 10.1056/NEJMoa021993.
174. Ridker PM, Buring JE, Cook NR, Rifai N, C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003 107 391 397
175. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention; American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 499 511
176. Salmon JE, Roman MJ, Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008 121 suppl 1 S3 S8. doi: 10.1016/j.amjmed.2008.06.010.
177. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK, Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association [published corrections appear in Circulation. 2011;123:e624 and Circulation. 2011;124:e427]. Circulation 2011 123 1243 1262. doi: 10.1161/CIR.0b013e31820faaf8.
178. Ward MM, Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999 42 338 346. doi: 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U.
179. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D'Agostino RB, Kuller LH, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997 145 408 415
180. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ, Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009 53 944 951. doi: 10.1161/HYPERTENSIONAHA.109.130765.
181. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ, Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study [published correction appears in Stroke. 2006;37:2862]. Stroke 2006 37 1055 1059. doi: 10.1161/01.STR.0000206284.96739.ee.
182. Männistö T, Mendola P, Vääräsmäki M, Järvelin MR, Hartikainen AL, Pouta A, Suvanto E, Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013 127 681 690. doi: 10.1161/CIRCULATIONAHA.112.128751.
183. Bellamy L, Casas JP, Hingorani AD, Williams DJ, Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007 335 974. doi: 10.1136/bmj.39335.385301.BE.
184. Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM, Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? Epidemiol Rev 2014 36 57 70. doi: 10.1093/epirev/mxt006.
185. Ratner RE, Prevention of type 2 diabetes in women with previous gestational diabetes [published correction appears in Diabetes Care. 2007;30:3154]. Diabetes Care 2007 30 suppl 2 S242 S245. doi: 10.2337/dc07-s223.
186. Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL, Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002 186 751 756
187. ACOG Committee on Practice Bulletins-Gynecology ACOG Practice Bulletin: The use of hormonal contraception in women with coexisting medical conditions: Number 18, July 2000. Int J Gynaecol Obstet 2001 75 93 106
188. Petitti DB, Clinical practice: combination estrogen-progestin oral contraceptives [published correction appears in N Engl J Med. 2004;350:92]. N Engl J Med 2003 349 1443 1450
189. Shufelt CL, Bairey Merz CN, Contraceptive hormone use and cardiovascular disease [published correction appears in J Am Coll Cardiol. 2009;53:904]. J Am Coll Cardiol 2009 53 221 231
190. Polotsky HN, Polotsky AJ, Metabolic implications of menopause. Semin Reprod Med 2010 28 426 434
191. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 280 605 613
192. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA, Wenger NK, Raloxifene Use for The Heart (RUTH) Trial Investigators Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006 355 125 137. doi: 10.1056/NEJMoa062462.
193. Moran LJ, Misso ML, Wild RA, Norman RJ, Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010 16 347 363. doi: 10.1093/humupd/dmq001.
194. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ, Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation [withdrawn in J Clin Endocrinol Metab. 2015]. J Clin Endocrinol Metab 2008 93 1276 1284. doi: 10.1210/jc.2007-0425.
195. Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE, Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002 87 2013 2017. doi: 10.1210/jcem.87.5.8471.
196. Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE, Reichek N, Rogers WJ, Pohost GM, Kelsey SF, Sopko G, WISE Study Group Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003 41 413 419
197. Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V, WISE Study Group Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Fertil Steril 2006 85 1425 1431. doi: 10.1016/j.fertnstert.2006.01.009.
198. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR, Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007 50 1435 1441. doi: 10.1016/j.jacc.2007.06.037.
199. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P, Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013 368 987 998. doi: 10.1056/NEJMoa1209825.
200. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM, Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012 156 115 122. doi: 10.7326/0003-4819-156-2-201201170-00006.
201. Somers VK, Dyken ME, Mark AL, Abboud FM, Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993 328 303 307. doi: 10.1056/NEJM199302043280502.
202. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK, Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998 98 1071 1077
203. Webster R, Heeley E, Perceptions of risk: understanding cardiovascular disease. Risk Manag Healthc Policy 2010 3 49 60. doi: 10.2147/RMHP.S8288.
204. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, Kopin LA, Lungelow D, Cardiovascular Health Intervention Research and Translation Network Work Group on Global Coronary Heart Disease Risk The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med 2010 170 230 239. doi: 10.1001/archinternmed.2009.516.
205. Ridker PM, Buring JE, Rifai N, Cook NR, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score [published correction appears in JAMA. 2007;297:1433]. JAMA 2007 297 611 619. doi: 10.1001/jama.297.6.611.
206. O'Keefe-McCarthy S, Women's experiences of cardiac pain: a review of the literature [published correction appears in Can J Cardiovasc Nurs. 2009;19:3]. Can J Cardiovasc Nurs 2008 18 18 25
207. Hart PL, Women's perceptions of coronary heart disease: an integrative review. J Cardiovasc Nurs 2005 20 170 176
208. Isaksson RM, Brulin C, Eliasson M, Näslund U, Zingmark K, Older women's prehospital experiences of their first myocardial infarction. J Cardiovasc Nurs 2013 28 360 369. doi: 10.1097/JCN.0b013e31824bcebc.
209. McSweeney JC, Cleves MA, Zhao W, Lefler LL, Yang S, Cluster analysis of women's prodromal and acute myocardial infarction symptoms by race and other characteristics. J Cardiovasc Nurs 2010 25 311 322. doi: 10.1097/JCN.0b013e3181cfba15.
210. McSweeney JC, Women's narratives: evolving symptoms of myocardial infarction. J Women Aging 1998 10 67 83. doi: 10.1300/J074v10n02-06.
211. Gallagher R, Marshall AP, Fisher MJ, Symptoms and treatment-seeking responses in women experiencing acute coronary syndrome for the first time. Heart Lung 2010 39 477 484. doi: 10.1016/j.hrtlng.2009.10.019.
212. Hwang SY, Zerwic JJ, Jeong MH, Impact of prodromal symptoms on prehospital delay in patients with first-time acute myocardial infarction in Korea. J Cardiovasc Nurs 2011 26 194 201. doi: 10.1097/JCN.0b013e3181f3e2e0.
213. McSweeney J, Cleves MA, Fischer EP, Moser DK, Wei J, Pettey C, Rojo MO, Armbya N, Predicting coronary heart disease events in women: a longitudinal cohort study. J Cardiovasc Nurs 2014 29 482 492. doi: 10.1097/JCN.0b013e3182a409cc.
214. Pastorius Benziger C, Bernabe-Ortiz A, Miranda JJ, Bukhman G, Sex differences in health care-seeking behavior for acute coronary syndrome in a low income country, Peru. Crit Pathw Cardiol 2011 10 99 103. doi: 10.1097/HPC.0b013e318223e375.
215. McSweeney JC, Lefler LL, Crowder BF, What's wrong with me? Women's coronary heart disease diagnostic experiences. Prog Cardiovasc Nurs 2005 20 48 57
216. Maserejian NN, Link CL, Lutfey KL, Marceau LD, McKinlay JB, Disparities in physicians' interpretations of heart disease symptoms by patient gender: results of a video vignette factorial experiment. J Womens Health (Larchmt) 2009 18 1661 1667. doi: 10.1089/jwh.2008.1007.
217. Welch LC, Lutfey KE, Gerstenberger E, Grace M, Gendered uncertainty and variation in physicians' decisions for coronary heart disease: the double-edged sword of "atypical symptoms." J Health Soc Behav 2012 53 313 328. doi: 10.1177/0022146512456026.
218. Lutfey KE, Link CL, Grant RW, Marceau LD, McKinlay JB, Is certainty more important than diagnosis for understanding race and gender disparities? An experiment using coronary heart disease and depression case vignettes. Health Policy 2009 89 279 287. doi: 10.1016/j.healthpol.2008.06.007.
219. Chang AM, Mumma B, Sease KL, Robey JL, Shofer FS, Hollander JE, Gender bias in cardiovascular testing persists after adjustment for presenting characteristics and cardiac risk. Acad Emerg Med 2007 14 599 605. doi: 10.1197/j.aem.2007.03.1355.
220. Crilly M, Bundred P, Hu X, Leckey L, Johnstone F, Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary care. BMC Health Serv Res 2007 7 142. doi: 10.1186/1472-6963-7-142.
221. Adams A, Buckingham CD, Lindenmeyer A, McKinlay JB, Link C, Marceau L, Arber S, The influence of patient and doctor gender on diagnosing coronary heart disease. Sociol Health Illn 2008 30 1 18. doi: 10.1111/j.1467-9566.2007.01025.x.
222. Crilly MA, Bundred PE, Leckey LC, Johnstone FC, Gender bias in the clinical management of women with angina: another look at the Yentl syndrome. J Womens Health (Larchmt) 2008 17 331 342. doi: 10.1089/jwh.2007.0383.
223. Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, Dasgupta K, Norris CM, Pilote L, GENESIS PRAXY Team Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med 2013 173 1863 1871. doi: 10.1001/jamainternmed.2013.10149.
224. McSweeney JC, O'Sullivan P, Cleves MA, Lefler LL, Cody M, Moser DK, Dunn K, Kovacs M, Crane PB, Ramer L, Messmer PR, Garvin BJ, Zhao W, Racial differences in women's prodromal and acute symptoms of myocardial infarction. Am J Crit Care 2010 19 63 73. doi: 10.4037/ajcc2010372.
225. Coventry LL, Finn J, Bremner AP, Sex differences in symptom presentation in acute myocardial infarction: a systematic review and meta-analysis. Heart Lung 2011 40 477 491. doi: 10.1016/j.hrtlng.2011.05.001.
226. Davis LL, Mishel M, Moser DK, Esposito N, Lynn MR, Schwartz TA, Thoughts and behaviors of women with symptoms of acute coronary syndrome. Heart Lung 2013 42 428 435. doi: 10.1016/j.hrtlng.2013.08.001.
227. Lefler LL, McSweeney JC, Garner KK, "Missing pieces": exploring cardiac risk perceptions in older women. Res Gerontol Nurs 2013 6 107 115. doi: 10.3928/19404921-20121217-01.
228. Sullivan AL, Beshansky JR, Ruthazer R, Murman DH, Mader TJ, Selker HP, Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study. Circ Cardiovasc Qual Outcomes 2014 7 86 94. doi: 10.1161/CIRCOUTCOMES.113.000396.
229. Alshahrani H, McConkey R, Wilson J, Youssef M, Fitzsimons D, Female gender doubles pre-hospital delay times for patients experiencing ST segment elevation myocardial infarction in Saudi Arabia. Eur J Cardiovasc Nurs 2014 13 399 407. doi: 10.1177/1474515113507159.
230. Wang X, Hsu LL, Treatment-seeking delays in patients with acute myocardial infarction and use of the emergency medical service. J Int Med Res 2013 41 231 238. doi: 10.1177/0300060512474567.
231. Mussi FC, Gibaut Mde A, Damasceno CA, Mendes AS, Guimarães AC, Santos CA, Sociodemographic and clinical factors associated with the decision time for seeking care in acute myocardial infarction. Rev Lat Am Enfermagem 2013 21 1248 1257. doi: 10.1590/0104-1169.3178.2361.
232. Melberg T, Kindervaag B, Rosland J, Gender-specific time delays to primary PCI in STEMI: a consequence of the presentation or the management at the EMC centre? Eur Heart J 2013 34 5919. doi: 10.1093/eurheartj/eht311.5919.
233. Banks AD, Dracup K, Are there gender differences in the reasons why African Americans delay in seeking medical help for symptoms of an acute myocardial infarction? Ethn Dis 2007 17 221 227
234. De Luca G, Gibson MC, Hof AW, Cutlip D, Zeymer U, Noc M, Maioli M, Zorman S, Gabriel MH, Secco GG, Emre A, Dudek D, Rakowski T, Gyongyosi M, Huber K, Bellandi F, EGYPT Cooperation Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors. J Cardiovasc Med (Hagerstown) 2013 14 815 820. doi: 10.2459/JCM.0b013e32835fcb38.
235. Kirchberger I, Heier M, Wende R, von Scheidt W, Meisinger C, The patient's interpretation of myocardial infarction symptoms and its role in the decision process to seek treatment: the MONICA/KORA Myocardial Infarction Registry. Clin Res Cardiol 2012 101 909 916. doi: 10.1007/s00392-012-0475-8.
236. Banks AD, Malone RE, Accustomed to enduring: experiences of African-American women seeking care for cardiac symptoms. Heart Lung 2005 34 13 21. doi: 10.1016/j.hrtlng.2004.08.001.
237. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, Kiefe CI, Frederick PD, Sopko G, Zheng ZJ, NRMI Investigators Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012 307 813 822. doi: 10.1001/jama.2012.199.
238. Rosenfeld AG, Lindauer A, Darney BG, Understanding treatment-seeking delay in women with acute myocardial infarction: descriptions of decision-making patterns. Am J Crit Care 2005 14 285 293
239. Luepker RV, Raczynski JM, Osganian S, Goldberg RJ, Finnegan JR Jr, Hedges JR, Goff DC Jr, Eisenberg MS, Zapka JG, Feldman HA, Labarthe DR, McGovern PG, Cornell CE, Proschan MA, Simons-Morton DG, Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: the Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA 2000 284 60 67
240. Dracup K, McKinley S, Riegel B, Moser DK, Meischke H, Doering LV, Davidson P, Paul SM, Baker H, Pelter M, A randomized clinical trial to reduce patient prehospital delay to treatment in acute coronary syndrome. Circ Cardiovasc Qual Outcomes 2009 2 524 532. doi: 10.1161/CIRCOUTCOMES.109.852608.
241. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA, Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol 1995 25 807 814. doi: 10.1016/0735-1097(94)00507-M.
242. Crea F, Lanza GA, Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004 90 457 463
243. Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM, Chest pain in women: clinical, investigative, and prognostic features. BMJ 1994 308 883 886
244. Banks K, Puttagunta D, Murphy S, Lo M, McGuire DK, de Lemos JA, Chang AY, Grundy SM, Khera A, Clinical characteristics, vascular function, and inflammation in women with angina in the absence of coronary atherosclerosis: the Dallas Heart Study. JACC Cardiovasc Imaging 2011 4 65 73. doi: 10.1016/j.jcmg.2010.10.006.
245. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM, Sex, clinical presentation, and outcome in patients with acute coronary syndromes: Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999 341 226 232. doi: 10.1056/NEJM199907223410402.
246. Hochman JS, McCabe CH, Stone PH, Becker RC, Cannon CP, DeFeo-Fraulini T, Thompson B, Steingart R, Knatterud G, Braunwald E, Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB: TIMI Investigators: Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997 30 141 148
247. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, Braunwald E, Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 2002 288 3124 3129
248. Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe C, Thompson B, Chaitman B, Williams DO, Braunwald E, Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994 74 531 537
249. Bugiardini R, Bairey Merz CN, Angina with "normal" coronary arteries: a changing philosophy. JAMA 2005 293 477 484. doi: 10.1001/jama.293.4.477.
250. Douglas PS, Ginsburg GS, The evaluation of chest pain in women. N Engl J Med 1996 334 1311 1315. doi: 10.1056/NEJM199605163342007.
251. Milner KA, Funk M, Arnold A, Vaccarino V, Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J 2002 143 283 288
252. Canto JG, Goldberg RJ, Hand MM, Bonow RO, Sopko G, Pepine CJ, Long T, Symptom presentation of women with acute coronary syndromes: myth vs reality. Arch Intern Med 2007 167 2405 2413. doi: 10.1001/archinte.167.22.2405.
253. Rosengren A, Wallentin L, K Gitt A, Behar S, Battler A, Hasdai D, Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J 2004 25 663 670. doi: 10.1016/j.ehj.2004.02.023.
254. Tamura A, Naono S, Torigoe K, Hino M, Maeda S, Shinozaki K, Zaizen H, Kadota J, Gender differences in symptoms during 60-second balloon occlusion of the coronary artery. Am J Cardiol 2013 111 1751 1754. doi: 10.1016/j.amjcard.2013.02.026.
255. DeVon HA, Ryan CJ, Ochs AL, Shapiro M, Symptoms across the continuum of acute coronary syndromes: differences between women and men. Am J Crit Care 2008 17 14 24; quiz 25
256. Kreatsoulas C, Shannon HS, Giacomini M, Velianou JL, Anand SS, Reconstructing angina: cardiac symptoms are the same in women and men. JAMA Intern Med 2013 173 829 831. doi: 10.1001/jamainternmed.2013.229.
257. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CN, WISE Study Group Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol 2001 87 937 941, A3
258. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN, Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006 27 1408 1415. doi: 10.1093/eurheartj/ehl040.
259. Poon S, Goodman SG, Yan RT, Bugiardini R, Bierman AS, Eagle KA, Johnston N, Huynh T, Grondin FR, Schenck-Gustafsson K, Yan AT, Bridging the gender gap: insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. Am Heart J 2012 163 66 73. doi: 10.1016/j.ahj.2011.09.025.
260. Merz CN, The Yentl syndrome is alive and well. Eur Heart J 2011 32 1313 1315. doi: 10.1093/eurheartj/ehr083.
261. Radico F, Cicchitti V, Zimarino M, De Caterina R, Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv 2014 7 453 463. doi: 10.1016/j.jcin.2014.01.157.
262. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006 47 suppl S21 S29. doi: 10.1016/j.jacc.2004.12.084.
263. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM, National Institutes of Health-National Heart, Lung, and Blood Institute Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004 109 2993 2999. doi: 10.1161/01.CIR.0000130642.79868.B2.
264. Diamond GA, Forrester JS, Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979 300 1350 1358. doi: 10.1056/NEJM197906143002402.
265. Mieres JH, Gulati M, Bairey Merz N, Berman DS, Gerber TC, Hayes SN, Kramer CM, Min JK, Newby LK, Nixon JV, Srichai MB, Pellikka PA, Redberg RF, Wenger NK, Shaw LJ, on behalf of the American Heart Association Cardiac Imaging Committee of the Council on Clinical Cardiology; Cardiovascular Imaging and Intervention Committee of the Council on Cardiovascular Radiology and Intervention Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association [published correction appears in Circulation. 2014;130:e86]. Circulation 2014 130 350 379. doi: 10.1161/CIR.0000000000000061.
266. Kwok Y, Kim C, Grady D, Segal M, Redberg R, Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999 83 660 666
267. Hlatky MA, Pryor DB, Harrell FE Jr, Califf RM, Mark DB, Rosati RA, Factors affecting sensitivity and specificity of exercise electrocardiography: multivariable analysis. Am J Med 1984 77 64 71
268. Guiteras P, Chaitman BR, Waters DD, Bourassa MG, Scholl JM, Ferguson RJ, Wagniart P, Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women. Circulation 1982 65 1465 1474
269. Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS, Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the Lipid Research Clinics Prevalence Study. JAMA 2003 290 1600 1607. doi: 10.1001/jama.290.12.1600.
270. Shaw LJ, Olson MB, Kip K, Kelsey SF, Johnson BD, Mark DB, Reis SE, Mankad S, Rogers WJ, Pohost GM, Arant CB, Wessel TR, Chaitman BR, Sopko G, Handberg E, Pepine CJ, Bairey Merz CN, The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006 47 suppl S36 S43. doi: 10.1016/j.jacc.2005.03.080.
271. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED, Value of exercise treadmill testing in women [published correction appears in J Am Coll Cardiol. 1999;33:289]. J Am Coll Cardiol 1998 32 1657 1664
272. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F, Thomas JD, Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995 26 335 341
273. Heupler S, Mehta R, Lobo A, Leung D, Marwick TH, Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997 30 414 420
274. Arruda-Olson AM, Juracan EM, Mahoney DW, McCully RB, Roger VL, Pellikka PA, Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol 2002 39 625 631
275. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F, Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997 29 69 77
276. Santana-Boado C, Candell-Riera J, Castell-Conesa J, Aguadé-Bruix S, García-Burillo A, Canela T, González JM, Cortadellas J, Ortega D, Soler-Soler J, Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998 39 751 755
277. Amanullah AM, Berman DS, Hachamovitch R, Kiat H, Kang X, Friedman JD, Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 1997 80 132 137
278. Marwick TH, Shaw LJ, Lauer MS, Kesler K, Hachamovitch R, Heller GV, Travin MI, Borges-Neto S, Berman DS, Miller DD, The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease: Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999 106 172 178
279. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO, ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003 108 1404 1418. doi: 10.1161/01.CIR.0000080946.42225.4D.
280. Mieres JH, Shaw LJ, Hendel RC, Miller DD, Bonow RO, Berman DS, Heller GV, Mieres JH, Bairey-Merz CN, Berman DS, Bonow RO, Cacciabaudo JM, Heller GV, Hendel RC, Kiess MC, Miller DD, Polk DM, Shaw LJ, Smanio PE, Walsh MN, Writing Group on Perfusion Imaging in Women American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease: the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction] [published correction appears in J Nucl Cardiol. 2003;10:218]. J Nucl Cardiol 2003 10 95 101. doi: 10.1067/mnc.2003.130362.
281. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ, Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002 346 1948 1953. doi: 10.1056/NEJMoa012369.
282. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E, Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999 99 763 770
283. Buchthal SD, den Hollander JA, Merz CN, Rogers WJ, Pepine CJ, Reichek N, Sharaf BL, Reis S, Kelsey SF, Pohost GM, Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000 342 829 835. doi: 10.1056/NEJM200003233421201.
284. Jneid H, Fonarow GC, Cannon CP, Hernandez AF, Palacios IF, Maree AO, Wells Q, Bozkurt B, Labresh KA, Liang L, Hong Y, Newby LK, Fletcher G, Peterson E, Wexler L, on behalf of the Get With the Guidelines Steering Committee and Investigators Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008 118 2803 2810. doi: 10.1161/CIRCULATIONAHA.108.789800.
285. Bangalore S, Fonarow GC, Peterson ED, Hellkamp AS, Hernandez AF, Laskey W, Peacock WF, Cannon CP, Schwamm LH, Bhatt DL, on behalf of the Get With the Guidelines Steering Committee and Investigators Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med 2012 125 1000 1009. doi: 10.1016/j.amjmed.2011.11.016.
286. Naicker K, Liddy C, Singh J, Taljaard M, Hogg W, Quality of cardiovascular disease care in Ontario's primary care practices: a cross sectional study examining differences in guideline adherence by patient sex. BMC Fam Pract 2014 15 123. doi: 10.1186/1471-2296-15-123.
287. Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P, EUROASPIRE Study Group Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart 2010 96 1744 1749. doi: 10.1136/hrt.2010.196170.
288. Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, Manhapra A, Mallik S, Krumholz HM, National Registry of Myocardial Infarction Investigators Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005 353 671 682. doi: 10.1056/NEJMsa032214.
289. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, Brogan GX Jr, Boden WE, Roe MT, Ohman EM, Gibler WB, Newby LK, CRUSADE Investigators Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005 45 832 837. doi: 10.1016/j.jacc.2004.11.055.
290. Lewis WR, Ellrodt AG, Peterson E, Hernandez AF, LaBresh KA, Cannon CP, Pan W, Fonarow GC, Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the Get With The Guidelines Quality-Improvement Program. Circ Cardiovasc Qual Outcomes 2009 2 633 641. doi: 10.1161/CIRCOUTCOMES.108.824763.
291. Thanavaro JL, Moore SM, Anthony M, Narsavage G, Delicath T, Predictors of health promotion behavior in women without prior history of coronary heart disease. Appl Nurs Res 2006 19 149 155. doi: 10.1016/j.apnr.2005.07.006.
292. Moore LC, Kimble LP, Minick P, Perceptions of cardiac risk factors and risk-reduction behavior in women with known coronary heart disease. J Cardiovasc Nurs 2010 25 433 443. doi: 10.1097/JCN.0b013e3181defd58.
293. Murphy BM, Worcester MU, Elliott PC, Le Grande MR, Higgins RO, Goble AJ, Change in women's dietary fat intake following an acute cardiac event: extent, predictors and comparison with non-cardiac Australian women and older adults. Eur J Cardiovasc Nurs 2006 5 206 213. doi: 10.1016/j.ejcnurse.2006.01.002.
294. Patterson RE, Kristal AR, Coates RJ, Tylavsky FA, Ritenbaugh C, Van Horn L, Caggiula AW, Snetselaar L, Low-fat diet practices of older women: prevalence and implications for dietary assessment. J Am Diet Assoc 1996 96 670 679
295. Gans KM, Burkholder GJ, Risica PM, Lasater TM, Baseline fat-related dietary behaviors of white, Hispanic, and black participants in a cholesterol screening and education project in New England. J Am Diet Assoc 2003 103 699 706. doi: 10.1053/jada.2003.50135.
296. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A, American College of Sports Medicine; American Heart Association Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007 116 1081 1093. doi: 10.1161/CIRCULATIONAHA.107.185649.
297. Mozumdar A, Liguori G, DuBose K, Occupational physical activity and risk of coronary heart disease among active and non-active working-women of North Dakota: a Go Red North Dakota Study. Anthropol Anz 2012 69 201 219
298. Moss L, Crane PB, Exploring polypharmacy in elderly women after myocardial infarction. J Women Aging 2010 22 22 33. doi: 10.1080/08952840903488948.
299. Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, Alam T, Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm 2012 18 527 539
300. Moise N, Schwartz J, Bring R, Shimbo D, Kronish IM, Antihypertensive drug class and adherence: an electronic monitoring study. Am J Hypertens 2015 28 717 721. doi: 10.1093/ajh/hpu199.
301. Sicras Mainar A, Munoz Orti G, Font Ramos B, Majos Oro N, Navarro Artieda R, Ibanez Nolla J, Relationship of polymedication in controlling blood pressure: compliance, persistence, costs and incidence of new cardiovascular events [in Spanish]. Med Clin (Barc) 2013 141 53 61
302. Harmsen CG, Støvring H, Jarbøl DE, Nexøe J, Gyrd-Hansen D, Nielsen JB, Edwards A, Kristiansen IS, Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey. BMC Med Inform Decis Mak 2012 12 89. doi: 10.1186/1472-6947-12-89.
303. Smedley BD, Stith AY, Nelson ARE, Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care 2003 Washington, DC The National Academies Press
304. Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ, Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health 2006 96 2113 2121. doi: 10.2105/AJPH.2005.077628.
305. Rathore SS, Krumholz HM, Differences, disparities, and biases: clarifying racial variations in health care use. Ann Intern Med 2004 141 635 638
306. Hebert PL, Sisk JE, Howell EA, When does a difference become a disparity? Conceptualizing racial and ethnic disparities in health. Health Aff (Millwood) 2008 27 374 382. doi: 10.1377/hlthaff.27.2.374.
307. Balsa AI, McGuire TG, Prejudice, clinical uncertainty and stereotyping as sources of health disparities. J Health Econ 2003 22 89 116
308. Barnhart JM, Monrad ES, Cohen HW, Physicians' perceptions of the effect of nonclinical factors on coronary revascularization. Heart Dis 2003 5 313 319. doi: 10.1097/01.hdx.0000089868.93202.f0.
309. Barnhart JM, Wassertheil-Smoller S, The effect of race/ethnicity, sex, and social circumstances on coronary revascularization preferences: a vignette comparison. Cardiol Rev 2006 14 215 222. doi: 10.1097/01.crd.0000214180.24372.d5.
310. Burgess DJ, Fu SS, van Ryn M, Why do providers contribute to disparities and what can be done about it? J Gen Intern Med 2004 19 1154 1159. doi: 10.1111/j.1525-1497.2004.30227.x.
311. Denberg TD, Kim FJ, Flanigan RC, Fairclough D, Beaty BL, Steiner JF, Hoffman RM, The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma. Med Care 2006 44 1137 1141. doi: 10.1097/01.mlr.0000233684.27657.36.
312. Lutfey KE, Link CL, Marceau LD, Grant RW, Adams A, Arber S, Siegrist J, Bönte M, von dem Knesebeck O, McKinlay JB, Diagnostic certainty as a source of medical practice variation in coronary heart disease: results from a cross-national experiment of clinical decision making. Med Decis Making 2009 29 606 618. doi: 10.1177/0272989X09331811.
313. van Ryn M, Burke J, The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med 2000 50 813 828
314. Hamberg K, Gender bias in medicine. Womens Health (Lond Engl) 2008 4 237 243. doi: 10.2217/17455057.4.3.237.
315. Bernstein B, Kane R, Physicians' attitudes toward female patients. Med Care 1981 19 600 608
316. van Ryn M, Burgess D, Malat J, Griffin J, Physicians' perceptions of patients' social and behavioral characteristics and race disparities in treatment recommendations for men with coronary artery disease. Am J Public Health 2006 96 351 357. doi: 10.2105/AJPH.2004.041806.
317. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dubé R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ, The effect of race and sex on physicians' recommendations for cardiac catheterization [published correction appears in N Engl J Med. 1999;340:1130]. N Engl J Med 1999 340 618 626. doi: 10.1056/NEJM199902253400806.
318. Hamberg K, Risberg G, Johansson EE, Westman G, Gender bias in physicians' management of neck pain: a study of the answers in a Swedish national examination. J Womens Health Gend Based Med 2002 11 653 666. doi: 10.1089/152460902760360595.
319. Knutson KM, Mah L, Manly CF, Grafman J, Neural correlates of automatic beliefs about gender and race. Hum Brain Mapp 2007 28 915 930. doi: 10.1002/hbm.20320.
320. Greenwald AG, Banaji MR, Implicit social cognition: attitudes, self-esteem, and stereotypes. Psychol Rev 1995 102 4 27
321. Gupta VK, Turban DB, Bhawe NM, The effect of gender stereotype activation on entrepreneurial intentions. J Appl Psychol 2008 93 1053 1061. doi: 10.1037/0021-9010.93.5.1053.
322. Rudman LA, Greenwald AG, McGhee DE, Implicit self-concept and evaluative implicit gender stereotypes: self and ingroup share desirable traits. Pers Soc Psychol Bull 2001 27 1164 1178. doi: 10.1177/0146167201279009.
323. Blair I, Gordon B.Moskowitz, Implicit stereotypes and prejudice. In: Cognitive Social Psychology: The Princeton Symposium on the Legacy and Future of Social Cognition 2001 1st ed. Mahwah, NJ Lawrence Erlbaum Associates Publishers
324. Devine PG, Stereotypes and prejudice: their automatic and controlled components. Pers Soc Psychol 1989 56 5 18
325. Dovidio JF, Kawakami K, Johnson C, Johnson B, Howard A, On the nature of prejudice: automatic and controlled processes. J Exp Soc Psychol 1997 33 510 540
326. Blair IV, Havranek EP, Price DW, Hanratty R, Fairclough DL, Farley T, Hirsh HK, Steiner JF, Assessment of biases against Latinos and African Americans among primary care providers and community members. Am J Public Health 2013 103 92 98. doi: 10.2105/AJPH.2012.300812.
327. Waller T, Lampman C, Lupfer-Johnson G, Assessing bias against overweight individuals among nursing and psychology students: an implicit association test. J Clin Nurs 2012 21 3504 3512. doi: 10.1111/j.1365-2702.2012.04226.x.
328. Sabin JA, Marini M, Nosek BA, Implicit and explicit anti-fat bias among a large sample of medical doctors by BMI, race/ethnicity and gender. PLoS One 2012 7 e48448. doi: 10.1371/journal.pone.0048448.
329. van Ryn M, Saha S, Exploring unconscious bias in disparities research and medical education. JAMA 2011 306 995 996. doi: 10.1001/jama.2011.1275.
330. Yang Z, Huang P, Zhu X, Unconscious race and social class bias in medical students. JAMA 2011 306 2454; author reply 2454 2455. doi: 10.1001/jama.2011.1770.
331. Blair IV, Steiner JF, Havranek EP, Unconscious (implicit) bias and health disparities: where do we go from here? Perm J 2011 15 71 78
332. Greenwald AG, McGhee DE, Schwartz JL, Measuring individual differences in implicit cognition: the Implicit Association Test. J Pers Soc Psychol 1998 74 1464 1480
333. Greenwald AG, Nosek BA, Banaji MR, Understanding and using the Implicit Association Test, I: an improved scoring algorithm. J Pers Soc Psychol 2003 85 197 216
334. Nosek BA, Greenwald AG, Banaji MR, Understanding and using the Implicit Association Test, II: method variables and construct validity. Pers Soc Psychol Bull 2005 31 166 180. doi: 10.1177/0146167204271418.
335. Lane KA, Banaji MR, Nosek B, Greenwald A, Wittenbrink B, Schwarz N, Understanding and using the Implicit Association Test, IV: what we know (so far) about the method. In: Implicit Measures of Attitudes 2007 New York, NY Guilford Press 59 102
336. Eagly AH, Steffen VJ, Gender stereotypes stem from the distribution of women and men into social roles. J Pers Soc Psychol 1984 46 735 754
337. Isaac C, Lee B, Carnes M, Interventions that affect gender bias in hiring: a systematic review. Acad Med 2009 84 1440 1446. doi: 10.1097/ACM.0b013e3181b6ba00.
338. Rudman LA, Glick P, Prescriptive gender stereotypes and backlash toward agentic women. J Soc Issues 2001 57 743 762
339. Gorman EH, Gender stereotypes, same-gender preferences, and organizational variation in the hiring of women: evidence from law firms. Am Sociol Rev 2005 70 702 728
340. Burgess D, Borgida E, Who women are, who women should be: descriptive and prescriptive gender stereotyping in sex discrimination. Psychology, Public Policy, and Law 1999 5 665 692
341. Blair IV, Steiner JF, Hanratty R, Price DW, Fairclough DL, Daugherty SL, Bronsert M, Magid DJ, Havranek EP, An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control. J Gen Intern Med 2014 29 987 995. doi: 10.1007/s11606-014-2795-z.
342. Chae DH, Nuru-Jeter AM, Adler NE, Implicit racial bias as a moderator of the association between racial discrimination and hypertension: a study of Midlife African American men. Psychosom Med 2012 74 961 964. doi: 10.1097/PSY.0b013e3182733665.
343. Green AR, Carney DR, Pallin DJ, Ngo LH, Raymond KL, Iezzoni LI, Banaji MR, Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med 2007 22 1231 1238. doi: 10.1007/s11606-007-0258-5.
344. Haider AH, Sexton J, Sriram N, Cooper LA, Efron DT, Swoboda S, Villegas CV, Haut ER, Bonds M, Pronovost PJ, Lipsett PA, Freischlag JA, Cornwell EE 3rd, Association of unconscious race and social class bias with vignette-based clinical assessments by medical students. JAMA 2011 306 942 951. doi: 10.1001/jama.2011.1248.
345. Sabin JA, Greenwald AG, The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma. Am J Public Health 2012 102 988 995. doi: 10.2105/AJPH.2011.300621.